Ignite Creation Date:
2024-05-06 @ 3:46 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04748536
Status:
COMPLETED
Last Update Posted:
2021-04-26
First Post:
2021-02-01
Brief Title:
Safety and PK of Repeated Doses of IRL201104 in Healthy Volunteers
Sponsor:
Revolo Biotherapeutics
Organization:
Revolo Biotherapeutics
Study Overview
Official Title:
A Randomised Double-blind Placebo-controlled Parallel Group Study in Healthy Volunteers to Assess the Safety Tolerability and Pharmacokinetics of Multiple Ascending Doses of IRL201104 to Support a Future COVID-19 Patient Study
Status:
COMPLETED
Status Verified Date:
2021-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess the safety tolerability and pharmacokinetics of repeat doses of IRL201104 given to healthy volunteers
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None